Next, we examined several cancer-related signaling pathways in the NF2 LOF mutants-transduced MCF10A cells and found that expressing the NF2 LOF mutants did not affect the activation of YAP, AKT or ERK but largely enhanced the phosphorylation of JNK and its substrate c-Jun (Fig. 7f). The gene discussed is YAP1; the disease is cancer.